After loosing the CE Mark and the ANSM recall – MHRA statement on Allergan
MHRA statement on Allergan
More from ANSM - Agence Nationale de Sécurité du MédicamentMore posts in ANSM - Agence Nationale de Sécurité du Médicament »
- Draft ANSM’S GUIDELINE Cybersecurity of medical devices integrating software during their life cycle
- ANSM – France pilot on clinical investigations under the MDR (in French)
- The ANSM decides, as a precautionary measure, to withdraw from the market macrotextured breast implants and breast implants with polyurethane-coated surfaces
More from Breast ImplantsMore posts in Breast Implants »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- TGA – Current status of breast implant products in Australia
More from FranceMore posts in France »
- Draft ANSM’S GUIDELINE Cybersecurity of medical devices integrating software during their life cycle
- ANSM – France pilot on clinical investigations under the MDR (in French)
- The ANSM decides, as a precautionary measure, to withdraw from the market macrotextured breast implants and breast implants with polyurethane-coated surfaces
More from Medicines and Healthcare Products Regulatory Agency - MHRAMore posts in Medicines and Healthcare Products Regulatory Agency - MHRA »
- UK – Independent Medicines and Medical Devices Safety Review report and MHRA response
- UK – MHRA – Effective field safety notices (FSNs): guidance for manufacturers of medical devices
- UK – Medicines and Medical Devices Bill: overarching documents
- UK – MHRA revised guidance – Guidance Notified bodies for medical devices
- MHRA Revised Guidance – Clinical investigations of medical devices – guidance for manufacturers
Be First to Comment